Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining

Product Details
Customization: Available
Powder: Yes
Customized: Non-Customized
Gold Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

to see all verified strength labels (11)
  • Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining
  • Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining
  • Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining
  • Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining
  • Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining
  • Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining
Find Similar Products
  • Overview
  • Product Description
  • Other products recommended
Overview

Basic Info.

Model NO.
2mg
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Solid
Purity
>99%
Color
White
OEM
Wh@PP: +86*186*6189*1880
Customized Order
Yes
Dropshipping
Yes
Transport Package
Box
Specification
2mg 5mg
Trademark
QSC
Origin
China
Production Capacity
50000000

Product Description

Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining

Product Description

Myostatin (also known as growth differentiation factor 8, abbreviated GDF-8) is a myokine, a protein produced and released by myocytes that acts on muscle cells' autocrine function to inhibit myogenesis: muscle cell growth and differentiation. In humans it is encoded by the MSTN gene. Myostatin is a secreted growth differentiation factor that is a member of the TGF beta protein family.
Animals either lacking myostatin or treated with substances that block the activity of myostatin have significantly more muscle mass. Furthermore, individuals who have mutations in both copies of the myostatin gene have significantly more muscle mass and are stronger than normal. Blocking the activity of myostatin may have therapeutic application in treating muscle wasting diseases such as muscular dystrophy.

Product Name Top quality GDF-8
Packing 1box/10vials,1mg/vial
CAS No 901758-09-6
Molecular Formula C221H366N72O67S
Application Pharmaceutical raw materials
purity > 99.0%
 
The gene encoding myostatin was discovered in 1997 by geneticists Se-Jin Lee and Alexandra McPherron who produced a strain of mutant mice that lack the gene. These myostatin "knockout" mice have approximately twice as much muscle as normal mice. These mice were subsequently named "mighty mice".

Naturally occurring deficiencies of myostatin have been identified in cattle by Ravi Kambadur, whippets, and humans; in each case the result is a dramatic increase in muscle mass. A mutation in the 3' UTR of the myostatin gene in Texel sheep creates target sites for the microRNAs miR-1 and miR-206. This is likely to cause the muscular phenotype of this breed of sheep.
 
Other products recommended
Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining
Pharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle GainingPharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle GainingPharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle GainingPharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle GainingPharmaceutical Peptides Myostatin Peptide Powder CAS 901758-09-6 Gdf-8 for Muscle Gaining
 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier